Association of Prenatal Acetaminophen Exposure Measured in Meconium With Risk of Attention-Deficit/Hyperactivity Disorder Mediated by Frontoparietal Network Brain Connectivity
Author(s) -
Brennan H. Baker,
Claudia LugoCandelas,
Haotian Wu,
Hannah E. Laue,
Amélie Boivin,
Virginie Gillet,
Natalie Aw,
Tonima Rahman,
JeanFrançois Lepage,
Kevin Whittingstall,
JeanPhilippe Bellenger,
Jonathan Posner,
Larissa Takser,
Andrea Baccarelli
Publication year - 2020
Publication title -
jama pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.004
H-Index - 183
eISSN - 2168-6211
pISSN - 2168-6203
DOI - 10.1001/jamapediatrics.2020.3080
Subject(s) - medicine , attention deficit hyperactivity disorder , meconium , pregnancy , pediatrics , offspring , cohort study , acetaminophen , psychiatry , anesthesia , fetus , biology , genetics
Despite evidence of an association between prenatal acetaminophen exposure and attention-deficit/hyperactivity disorder (ADHD) in offspring, the drug is not contraindicated during pregnancy, possibly because prior studies have relied on maternal self-report, failed to quantify acetaminophen dose, and lacked mechanistic insight.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom